Загрузка...
Type 2 diabetes, thiazolidinediones, and cardiovascular risk
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Royal College of General Practitioners
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2702020/ https://ncbi.nlm.nih.gov/pubmed/19567003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3399/bjgp09X453440 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|